Company Intelligence
Deep Genomics
Deep Genomics provides enterprise-grade artificial intelligence solutions, delivering specialized Deep Genomics Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- Toronto, Canada
- Website
- www.deepgenomics.com
- Founded
- 2015
- Status
- Active
- Products
- 2
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Deep Genomics is a Healthcare AI company based in Toronto, Canada, founded in 2015.
Toronto AI-first TechBio company decoding RNA biology with foundation models for ASO, siRNA, and mRNA therapeutic design.
Verified founder profiles on Brel: Brendan Frey PhD, Brendan Frey.
What it builds
Deep Genomics Platform
Why It Matters
Deep Genomics provides enterprise-grade artificial intelligence solutions, delivering specialized Deep Genomics Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
ASO
Explore ASO by Deep Genomics. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture, and…
View product intelligence -
Foundation Model Platform
Explore Foundation Model Platform by Deep Genomics. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical…
View product intelligence
Founders
People linked to this company in the Brel founder graph.
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Deep Genomics
Industry
Industries served
- Biotechnology
Products
Technologies
Capabilities
Deep Genomics' foundation models learn directly from sequence to predict post-transcriptional regulatory events — miRNA binding sites and mRNA degradation patterns —…
Features
- Foundation Model Platform including REPRESS for microRNA binding and mRNA degradation prediction, plus complementary mode
- REPRESS for microRNA binding
- mRNA degradation prediction
- plus complementary models for RNA processing
- editing supporting therapeutic target identification
- mRNA design
Country
Use cases
Related companies
Official Resources
Official and developer links on file for this company.
Latest Developments
Verified developments and timeline notes on file.
Frequently Asked Questions
What does Deep Genomics do?
Deep Genomics specializes in artificial intelligence, developing Deep Genomics Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Deep Genomics based and when was it founded?
Deep Genomics is based in Canada and was founded in 2015.
What are the main products offered by Deep Genomics?
The flagship platform from Deep Genomics is Deep Genomics Platform, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Deep Genomics?
Deep Genomics primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.